GLAXOSMITHKLINEBusiness Directories,Company Directories

Company Name: Corporate Name:	GLAXOSMITHKLINE
Company Title:
Company Description:
Keywords to Search:
Company Address:	10691 Shellbridge Way,RICHMOND,BC,Canada
ZIP Code: Postal Code:	V6X
Telephone Number:	6042441056
Fax Number:	6042758612
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	170690
USA SIC Description:	PHARMACEUTICAL PRODUCTS WHOLESALE & MFRS
Number of Employees:
Sales Amount:
Credit History: Credit Report:	Good
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
GLENLYN HOMES LTD
GLEN W SMITH MASONRY
GLEN MAY FARMS LTD

Next company profile:
GLAXO SMITH KLINE
GLASSNER CONSULTING INC
GLASSLAND

Company News:

Home | GSK US
October 09 2024 Statement: Zantac (ranitidine) litigation – settlement agreements reached October 08 2024 GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV seasons View all press releases
Contact us - GSK
Learn more about our products and vaccines in the U S Vaccine Service Center (ordering, pricing, vaccines direct) - Tel: +1 866 475 8222 Integrity and Compliance - GSK’s Speak Up Integrity Lines can be used worldwide to report cases of unethical and illegal conduct
Products | GSK US
Products Learn more about our product portfolio and how we're prioritizing vaccines and specialty medicines to get ahead of disease together Below you can find the full A-Z list of our products available in the United States
Careers | GSK US
At GSK, we unite science, technology and talent to get ahead of disease together We aim to positively impact the health of 2 5 billion people by the end of the decade, as a successful, growing company where people can thrive
Company | GSK US
By pursuing this purpose together, we have the scale and expertise to positively impact the health of 2 5 billion people by the end of the decade In doing so, we will deliver stronger and more sustainable growth as a company where people can thrive Explore our Purpose, strategy and culture
At a glance | GSK US
At a glance Getting Ahead Together means preventing disease as well as treating it Globally, our portfolio spans vaccines, specialty and general medicines, with R D focused on science of the immune system, human genetics and advanced technologies
US FDA approves GSK’s AREXVY, the world’s first respiratory syncytial . . .
The approval is based on data from the positive pivotal AReSVi-006 phase III trial that showed exceptional efficacy in older adults, including those with underlying medical conditions, and in those with severe RSV disease
Press releases | GSK US
US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
Search jobs | GSK US
GSK plc Registered in England and Wales No 3888792 Registered office: 79 New Oxford Street, London United Kingdom WC1A 1DG GSK websites GSK Global website Locations selector Global Behind the science
Locations | GSK US
Locations | GSK US tbc